In vivo assessment of muscle membrane properties in the sodium channel myotonias

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Muscle and Nerve

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/mus.25956PMID 28877545PMCID PMC5839928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo assessment of muscle membrane properties in myotonic dystrophy

  2016cited by this paper
• Chloride channels in myotonia congenita assessed by velocity recovery cycles

  2014cited by this paper
• Validity of multi-fiber muscle velocity recovery cycles recorded at a single site using submaximal stimuli.

  2012cited by this paper
• Membrane dysfunction in Andersen‐Tawil syndrome assessed by velocity recovery cycles

  2012cited by this paper
• Muscle velocity recovery cycles: Effects of repetitive stimulation on two muscles

  2012cited by this paper
• Refined exercise testing can aid dna‐based diagnosis in muscle channelopathies

  2011cited by this paper
• Velocity recovery cycles of human muscle action potentials: repeatability and variability.

  2011cited by this paper
• Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles.

  2011cited by this paper
• Velocity recovery cycles of human muscle action potentials in chronic renal failure.

  2010cited by this paper
• Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia

  2009cited by this paper
• Pathomechanisms in channelopathies of skeletal muscle and brain.

  2006cited by this paper
• Electromyography guides toward subgroups of mutations in muscle channelopathies

  2004cited by this paper
• Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V

  2003cited by this paper
• Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker

  1996cited by this paper
• Different effects on gating of three myotonia‐causing mutations in the inactivation gate of the human muscle sodium channel.

  1995cited by this paper
• K(+)‐aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation.

  1994cited by this paper
• Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro.

  1994cited by this paper
• Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III‐IV linker.

  1993cited by this paper

• Muscle excitability testing: Age and sex dependency of normative data

  2025cites this paper
• Inherited myotonias.

  2024cites this paper
• Muscle excitability testing.

  2024cites this paper
• Muscle velocity recovery cycles in myopathy.

  2023cites this paper
• Excitability properties of mouse and human skeletal muscle fibres compared by muscle velocity recovery cycles

  2022cites this paper
• Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double‐blind placebo‐controlled cross‐over study

  2022cites this paper
• Muscle Ionic Shifts During Exercise: Implications for Fatigue and Exercise Performance.

  2021cites this paper
• Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.

  2021cites this paper
• Buprenorphine may be effective for treatment of paramyotonia congenita

  2021cites this paper
• Critical illness myopathy and polyneuropathy in Covid-19: Is it a distinct entity?

  2021cites this paper
• Ageing contributes to phenotype transition in a mouse model of periodic paralysis

  2021cites this paper
• Effect of Intermittent High Frequency Stimulation on Muscle Velocity Recovery Cycle Recordings.

  2021cites this paper
• Current Treatment Options for Patients with Myotonic Dystrophy Type 2

  2021cites this paper
• The role of potassium in muscle membrane dysfunction in end-stage renal disease.

  2021cites this paper
• Leg pain in neuropathic postural tachycardia syndrome is associated with altered muscle membrane properties

  2021cites this paper
• Serum electrolyte concentrations and skeletal muscle excitability in vivo.

  2021cites this paper
• MScanFit motor unit number estimation and muscle velocity recovery cycle recordings in diabetic polyneuropathy.

  2020cites this paper
• In vivo assessment of interictal sarcolemmal membrane properties in hypokalaemic and hyperkalaemic periodic paralysis.

  2020influential citation
• Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties.

  2020cites this paper
• MScanFit MUNE and Muscle Velocity Recovery Cycle recordings in ALS patients

  2019influential citation
• Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation

  2019cites this paper
• Muscle velocity recovery cycles: An evolving technique for assessing muscle fiber membrane properties.

  2019cites this paper
• Muscle velocity recovery cycles in neurogenic muscles.

  2019cites this paper
• MScanFit motor unit number estimation (MScan) and muscle velocity recovery cycle recordings in amyotrophic lateral sclerosis patients.

  2019cites this paper
• Muscular cramp: causes and management

  2018cites this paper